Early Cure Pharmacy Private Limited, a active private limited company, was established on 21 December 2011 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U52100DL2011PTC229074. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Relief Retails Prvate Limited. It upholds a compliant status. Its leadership includes Sangita Devi (Director), Harishchandra Kumar (Director), Neeraj Garg (Director). Past directors included Niru Sunil Singhal, Sunil Singhal, Sapna Bansal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No 113 & 114, First Floor, Plot No 1, Lsc Gazipur, Patparganj, New Delhi, Delhi, 110092.
U52100DL2011PTC229074
229074
21 December 2011
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Early Cure Pharmacy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangita Devi | Director | 27 Dec 2021 | Current |
| Harishchandra Kumar | Director | 27 Dec 2021 | Current |
| Neeraj Garg | Director | 31 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jan 2017 | Past |
| Pramod Abcsdd | Director | 30 Jan 2017 | Past |
| Pramod Abcsdd | Managing Director | 27 Dec 2021 | Past |
| Pramod Abcsdd | Director | 21 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Early Cure Pharmacy Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.99% decrease. The company also saw a substantial fall in profitability, with a 28.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 200.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Early Cure Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Early Cure Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Early Cure Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Early Cure Pharmacy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Early Cure Pharmacy Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Early Cure Pharmacy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Sangita Devi was appointed as a Director was appointed as a Director on 27 Dec 2021 & has been associated with this company since 4 years 18 days . was recorded as a recent event.
Progress on Harishchandra Kumar was appointed as a Director was appointed as a Director on 27 Dec 2021 & has been associated with this company since 4 years 18 days . was documented.
The activity Neeraj Garg was appointed as a Director was appointed as a Director on 31 Jan 2017 & has been associated with this company since 8 years 11 months . was completed.
The activity Early Cure Pharmacy Private Limited was registered on 21 Dec 2011 with Roc Delhi & aged 14 years 25 days as per MCA records. was completed.
The CIN of Early Cure Pharmacy Private Limited is U52100DL2011PTC229074.
Early Cure Pharmacy Private Limited is headquartered at Shop No 113 & 114, First Floor, Plot No 1, Lsc Gazipur, Patparganj, New Delhi, Delhi, 110092.
Early Cure Pharmacy Private Limited was incorporated on 21 December 2011.
The current directors of Early Cure Pharmacy Private Limited are
The primary industry of Early Cure Pharmacy Private Limited is Pharma.
Early Cure Pharmacy Private Limited is unlisted.
The authorized capital of Early Cure Pharmacy Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Early Cure Pharmacy Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX